

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.45882528 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.45882528 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.45882528 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.45882528 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.45882528 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.45882528 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.19280130 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.84518692 |
| 9 | mannose metabolic process (GO:0006013) | 4.79738907 |
| 10 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.41406309 |
| 11 | response to host immune response (GO:0052572) | 4.41406309 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18430401 |
| 13 | microglial cell activation (GO:0001774) | 4.09849595 |
| 14 | response to peptidoglycan (GO:0032494) | 4.05677735 |
| 15 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.05305048 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.90373421 |
| 17 | response to host (GO:0075136) | 3.87030204 |
| 18 | response to host defenses (GO:0052200) | 3.87030204 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.87030204 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.86906991 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 3.84113228 |
| 22 | I-kappaB phosphorylation (GO:0007252) | 3.64606761 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.62694963 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.53748024 |
| 25 | superoxide anion generation (GO:0042554) | 3.47150677 |
| 26 | positive regulation of heat generation (GO:0031652) | 3.46655828 |
| 27 | respiratory burst (GO:0045730) | 3.45592832 |
| 28 | macrophage activation (GO:0042116) | 3.42196332 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.41274890 |
| 30 | barbed-end actin filament capping (GO:0051016) | 3.41234219 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40910470 |
| 32 | protein localization to endosome (GO:0036010) | 3.37558469 |
| 33 | glycosphingolipid catabolic process (GO:0046479) | 3.31192906 |
| 34 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.30838286 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.29940639 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24784884 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24784884 |
| 38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.20924477 |
| 39 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.18962114 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12955565 |
| 41 | regulation of leukocyte degranulation (GO:0043300) | 3.12745231 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10634804 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.10596886 |
| 44 | melanin biosynthetic process (GO:0042438) | 3.10539603 |
| 45 | pinocytosis (GO:0006907) | 3.08355208 |
| 46 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05988429 |
| 47 | regulation of cholesterol storage (GO:0010885) | 3.01810583 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00947269 |
| 49 | amino sugar catabolic process (GO:0046348) | 2.97708653 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 2.97263320 |
| 51 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.96431916 |
| 52 | melanin metabolic process (GO:0006582) | 2.95454865 |
| 53 | granulocyte activation (GO:0036230) | 2.94214682 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 2.93188059 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92140153 |
| 56 | glycolipid catabolic process (GO:0019377) | 2.91590669 |
| 57 | regulation of fever generation (GO:0031620) | 2.91248946 |
| 58 | negative regulation of cell killing (GO:0031342) | 2.90666257 |
| 59 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.90666257 |
| 60 | response to thyroid hormone (GO:0097066) | 2.89965596 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 2.89199928 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86995150 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 2.86354880 |
| 64 | basic amino acid transport (GO:0015802) | 2.83989095 |
| 65 | low-density lipoprotein particle clearance (GO:0034383) | 2.83240396 |
| 66 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82297069 |
| 67 | response to laminar fluid shear stress (GO:0034616) | 2.82093570 |
| 68 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.81909924 |
| 69 | reactive oxygen species biosynthetic process (GO:1903409) | 2.81532464 |
| 70 | response to type I interferon (GO:0034340) | 2.80632237 |
| 71 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.80441504 |
| 72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80348370 |
| 73 | natural killer cell mediated immunity (GO:0002228) | 2.79285685 |
| 74 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.79285685 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.78776896 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.78776896 |
| 77 | neutrophil activation (GO:0042119) | 2.78676496 |
| 78 | detection of bacterium (GO:0016045) | 2.77604247 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 2.76372462 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 2.73797556 |
| 81 | negative regulation of lipid storage (GO:0010888) | 2.73050776 |
| 82 | germinal center formation (GO:0002467) | 2.72826079 |
| 83 | eosinophil chemotaxis (GO:0048245) | 2.72275487 |
| 84 | semaphorin-plexin signaling pathway (GO:0071526) | 2.71475996 |
| 85 | regulation of heat generation (GO:0031650) | 2.70542541 |
| 86 | positive thymic T cell selection (GO:0045059) | 2.70073981 |
| 87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68113007 |
| 88 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67513737 |
| 89 | stress fiber assembly (GO:0043149) | 2.66737677 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 2.64627157 |
| 91 | response to interferon-alpha (GO:0035455) | 2.62159626 |
| 92 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61629437 |
| 93 | regulation of ARF GTPase activity (GO:0032312) | 2.61355485 |
| 94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60649711 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 2.60084353 |
| 96 | intracellular pH reduction (GO:0051452) | 2.58666404 |
| 97 | monocyte chemotaxis (GO:0002548) | 2.56220660 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.55800618 |
| 99 | phagosome maturation (GO:0090382) | 2.55378743 |
| 100 | detection of external biotic stimulus (GO:0098581) | 2.55154882 |
| 101 | modulation by virus of host process (GO:0019054) | 2.54891917 |
| 102 | adhesion of symbiont to host (GO:0044406) | 2.54495326 |
| 103 | positive regulation of receptor recycling (GO:0001921) | 2.54388347 |
| 104 | L-amino acid import (GO:0043092) | 2.53280413 |
| 105 | oligosaccharide catabolic process (GO:0009313) | 2.52527451 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52362986 |
| 107 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.52032840 |
| 108 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51860508 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51652103 |
| 110 | regulation of regulated secretory pathway (GO:1903305) | 2.51073804 |
| 111 | detection of biotic stimulus (GO:0009595) | 2.49765512 |
| 112 | apoptotic cell clearance (GO:0043277) | 2.49443480 |
| 113 | lipoprotein transport (GO:0042953) | 2.49353733 |
| 114 | plasma lipoprotein particle clearance (GO:0034381) | 2.48965405 |
| 115 | regulation of extracellular matrix disassembly (GO:0010715) | 2.48959643 |
| 116 | cell-cell junction maintenance (GO:0045217) | 2.47696126 |
| 117 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.47490850 |
| 118 | regulation of chemokine biosynthetic process (GO:0045073) | 2.45513899 |
| 119 | detection of other organism (GO:0098543) | 2.45093018 |
| 120 | activation of MAPKKK activity (GO:0000185) | 2.44836751 |
| 121 | N-acetylneuraminate metabolic process (GO:0006054) | 2.44081868 |
| 122 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.43267426 |
| 123 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.42027580 |
| 124 | basement membrane organization (GO:0071711) | 2.42013449 |
| 125 | ceramide catabolic process (GO:0046514) | 2.41119681 |
| 126 | apoptotic process involved in morphogenesis (GO:0060561) | 2.40986673 |
| 127 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.40837589 |
| 128 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40820294 |
| 129 | activation of JUN kinase activity (GO:0007257) | 2.40738127 |
| 130 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.39961404 |
| 131 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39647812 |
| 132 | virion attachment to host cell (GO:0019062) | 2.37788417 |
| 133 | adhesion of symbiont to host cell (GO:0044650) | 2.37788417 |
| 134 | thymic T cell selection (GO:0045061) | 2.37606181 |
| 135 | eosinophil migration (GO:0072677) | 2.37287108 |
| 136 | cellular extravasation (GO:0045123) | 2.36218745 |
| 137 | positive regulation of mast cell degranulation (GO:0043306) | 2.34922504 |
| 138 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.34922504 |
| 139 | negative regulation of mast cell activation (GO:0033004) | 2.34801128 |
| 140 | regulation of podosome assembly (GO:0071801) | 2.34664093 |
| 141 | negative regulation of cell size (GO:0045792) | 2.34509691 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34414641 |
| 143 | hyaluronan catabolic process (GO:0030214) | 2.33905944 |
| 144 | regulation of monocyte differentiation (GO:0045655) | 2.33107610 |
| 145 | positive regulation of cholesterol efflux (GO:0010875) | 2.32252589 |
| 146 | positive regulation of protein dephosphorylation (GO:0035307) | 2.31760126 |
| 147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.31645300 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.31166086 |
| 149 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.30662174 |
| 150 | superoxide metabolic process (GO:0006801) | 2.29755433 |
| 151 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.29204581 |
| 152 | positive regulation of mast cell activation (GO:0033005) | 2.28880051 |
| 153 | cell adhesion mediated by integrin (GO:0033627) | 2.28800155 |
| 154 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27778565 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.27470053 |
| 156 | myeloid dendritic cell differentiation (GO:0043011) | 2.26533737 |
| 157 | regulation of superoxide anion generation (GO:0032928) | 2.26334110 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.25437118 |
| 159 | macroautophagy (GO:0016236) | 2.25258756 |
| 160 | peptide catabolic process (GO:0043171) | 2.23967649 |
| 161 | lymphocyte chemotaxis (GO:0048247) | 2.23818588 |
| 162 | positive regulation of phagocytosis (GO:0050766) | 2.23745932 |
| 163 | cytokine secretion (GO:0050663) | 2.23340088 |
| 164 | positive regulation of lipid storage (GO:0010884) | 2.23105611 |
| 165 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.22490915 |
| 166 | protein retention in ER lumen (GO:0006621) | 2.22247274 |
| 167 | positive regulation of extracellular matrix organization (GO:1903055) | 2.22086775 |
| 168 | pentose-phosphate shunt (GO:0006098) | 2.21765221 |
| 169 | regulation of lipid kinase activity (GO:0043550) | 2.21320499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68604488 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54604336 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.85064996 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.36610700 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.35025404 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.25126332 |
| 7 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.22434325 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10576281 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.91877046 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.59242669 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.52723871 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.42101889 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41147016 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36046529 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31697341 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.24996663 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21115457 |
| 18 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.19453302 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00353057 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00251045 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98124646 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97894026 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90917447 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85818673 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84697937 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84260745 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82997754 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69146125 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68444093 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67163144 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66450737 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63504275 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.62384451 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62331451 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61473614 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60361614 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59838098 |
| 38 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55329395 |
| 39 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.53685813 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.51670530 |
| 41 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51212938 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50965779 |
| 43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.50692790 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50546350 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50129624 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49816674 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48695531 |
| 48 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48028793 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47604184 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44040097 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43333777 |
| 52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.42813441 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42717636 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42607006 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41534163 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41287912 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40126230 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39792624 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39484054 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38655583 |
| 61 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.37366394 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36984152 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36556203 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35593204 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.35478985 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33005958 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31547124 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30525361 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30128889 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29686080 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29681412 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29392136 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29305917 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29203894 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29185437 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27850351 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26898370 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26200974 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.25959110 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25803655 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25417882 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25280618 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24762435 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23967861 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23420965 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20560647 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20385898 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20385898 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18972098 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18185694 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17153092 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16435500 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16032724 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13050900 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12994662 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12721599 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12604703 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11628091 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11130912 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10828956 |
| 101 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10687707 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10550728 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09531326 |
| 104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08241713 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07546155 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07068591 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05167909 |
| 108 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04324974 |
| 109 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03990351 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03847512 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03784735 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01674563 |
| 113 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01155740 |
| 114 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00536278 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99100476 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97057867 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96811011 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95806019 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95324879 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95299602 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95197003 |
| 122 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95183659 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94585314 |
| 124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94503657 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94218624 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93782221 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93586683 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.92785445 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92639999 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92254971 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91637779 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91633646 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91560491 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90222499 |
| 135 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89536358 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.89420152 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89226649 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87145428 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86932193 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86294671 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85622071 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84156406 |
| 143 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84060596 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83716714 |
| 145 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83630466 |
| 146 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82968342 |
| 147 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82249429 |
| 148 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81430656 |
| 149 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80586128 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79691353 |
| 151 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.79385237 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78739564 |
| 153 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.77879389 |
| 154 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.77879389 |
| 155 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77357769 |
| 156 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77176087 |
| 157 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77027656 |
| 158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74016189 |
| 159 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72757262 |
| 160 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.72755117 |
| 161 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72114624 |
| 162 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.71523026 |
| 163 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.71041742 |
| 164 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70864922 |
| 165 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70777914 |
| 166 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69857359 |
| 167 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69635180 |
| 168 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.68934408 |
| 169 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68460744 |
| 170 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68449130 |
| 171 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68415564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.76961105 |
| 2 | * MP0005058_abnormal_lysosome_morphology | 3.53682422 |
| 3 | MP0003303_peritoneal_inflammation | 3.34629462 |
| 4 | MP0003436_decreased_susceptibility_to | 3.30694562 |
| 5 | MP0004510_myositis | 3.14067177 |
| 6 | MP0006082_CNS_inflammation | 3.13217378 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.01409445 |
| 8 | * MP0003172_abnormal_lysosome_physiology | 2.75364392 |
| 9 | * MP0002419_abnormal_innate_immunity | 2.73729374 |
| 10 | MP0009840_abnormal_foam_cell | 2.61818610 |
| 11 | MP0009785_altered_susceptibility_to | 2.46002596 |
| 12 | MP0003724_increased_susceptibility_to | 2.42791181 |
| 13 | MP0001790_abnormal_immune_system | 2.42020088 |
| 14 | MP0005387_immune_system_phenotype | 2.42020088 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.37597160 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.30696977 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.25891313 |
| 18 | MP0005025_abnormal_response_to | 2.17941680 |
| 19 | MP0003690_abnormal_glial_cell | 2.16394574 |
| 20 | MP0005171_absent_coat_pigmentation | 2.14995365 |
| 21 | MP0000604_amyloidosis | 2.13684073 |
| 22 | MP0001849_ear_inflammation | 2.11744550 |
| 23 | MP0005257_abnormal_intraocular_pressure | 2.07796857 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.01509614 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.98277224 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.95082231 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.94150172 |
| 28 | MP0005409_darkened_coat_color | 1.91471317 |
| 29 | MP0004858_abnormal_nervous_system | 1.89719023 |
| 30 | MP0004947_skin_inflammation | 1.87323445 |
| 31 | * MP0002452_abnormal_antigen_presenting | 1.84882277 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.78651066 |
| 33 | MP0003075_altered_response_to | 1.76055999 |
| 34 | MP0003195_calcinosis | 1.75582993 |
| 35 | MP0009764_decreased_sensitivity_to | 1.74713845 |
| 36 | MP0003329_amyloid_beta_deposits | 1.73235510 |
| 37 | MP0002723_abnormal_immune_serum | 1.70184788 |
| 38 | MP0009278_abnormal_bone_marrow | 1.67964191 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.67474929 |
| 40 | MP0001800_abnormal_humoral_immune | 1.65550741 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.60015638 |
| 42 | * MP0002998_abnormal_bone_remodeling | 1.57947582 |
| 43 | MP0003279_aneurysm | 1.57329768 |
| 44 | MP0008469_abnormal_protein_level | 1.53617544 |
| 45 | MP0005360_urolithiasis | 1.52887804 |
| 46 | MP0005083_abnormal_biliary_tract | 1.48781937 |
| 47 | MP0000685_abnormal_immune_system | 1.45945085 |
| 48 | * MP0008260_abnormal_autophagy | 1.45710977 |
| 49 | MP0002254_reproductive_system_inflammat | 1.45246604 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.44582855 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.44582855 |
| 52 | MP0001958_emphysema | 1.44304685 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.42688349 |
| 54 | MP0003448_altered_tumor_morphology | 1.36720996 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.36523489 |
| 56 | * MP0001819_abnormal_immune_cell | 1.32808405 |
| 57 | MP0005671_abnormal_response_to | 1.32737712 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.32668117 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.30217074 |
| 60 | MP0000343_altered_response_to | 1.30119771 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.28669130 |
| 62 | * MP0002420_abnormal_adaptive_immunity | 1.28083812 |
| 63 | MP0005451_abnormal_body_composition | 1.24895528 |
| 64 | MP0005164_abnormal_response_to | 1.19368722 |
| 65 | MP0005310_abnormal_salivary_gland | 1.18561775 |
| 66 | MP0005166_decreased_susceptibility_to | 1.17350330 |
| 67 | MP0000371_diluted_coat_color | 1.14330324 |
| 68 | MP0002090_abnormal_vision | 1.10400415 |
| 69 | MP0002405_respiratory_system_inflammati | 1.09651027 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.08845399 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.08350314 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.05562446 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.05443151 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.04426049 |
| 75 | MP0003091_abnormal_cell_migration | 1.00785989 |
| 76 | MP0000920_abnormal_myelination | 0.99978517 |
| 77 | MP0005390_skeleton_phenotype | 0.99389826 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.99275231 |
| 79 | MP0009763_increased_sensitivity_to | 0.98526582 |
| 80 | MP0002075_abnormal_coat/hair_pigmentati | 0.97784126 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.97395674 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.96548004 |
| 83 | MP0002398_abnormal_bone_marrow | 0.96418744 |
| 84 | MP0003045_fibrosis | 0.95957051 |
| 85 | MP0005023_abnormal_wound_healing | 0.95886787 |
| 86 | MP0002933_joint_inflammation | 0.95479766 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.95011668 |
| 88 | MP0005408_hypopigmentation | 0.93907533 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.93110268 |
| 90 | MP0005197_abnormal_uvea_morphology | 0.91938557 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.91844653 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 0.91246563 |
| 93 | MP0005670_abnormal_white_adipose | 0.90863671 |
| 94 | MP0001853_heart_inflammation | 0.89627438 |
| 95 | MP0000678_abnormal_parathyroid_gland | 0.87898873 |
| 96 | * MP0002429_abnormal_blood_cell | 0.86777611 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.84830493 |
| 98 | MP0001851_eye_inflammation | 0.84689836 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.84181393 |
| 100 | MP0004742_abnormal_vestibular_system | 0.83819367 |
| 101 | MP0010329_abnormal_lipoprotein_level | 0.83765489 |
| 102 | MP0004381_abnormal_hair_follicle | 0.83484830 |
| 103 | * MP0003634_abnormal_glial_cell | 0.83459687 |
| 104 | MP0003136_yellow_coat_color | 0.82478147 |
| 105 | MP0000609_abnormal_liver_physiology | 0.80779236 |
| 106 | * MP0003795_abnormal_bone_structure | 0.79223384 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.78452961 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.77247706 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.77218088 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.77152009 |
| 111 | MP0002722_abnormal_immune_system | 0.77132255 |
| 112 | MP0004130_abnormal_muscle_cell | 0.76616857 |
| 113 | MP0010155_abnormal_intestine_physiology | 0.75418796 |
| 114 | MP0000249_abnormal_blood_vessel | 0.75187229 |
| 115 | * MP0000716_abnormal_immune_system | 0.74998660 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.74904893 |
| 117 | MP0001186_pigmentation_phenotype | 0.74745042 |
| 118 | MP0001873_stomach_inflammation | 0.74398542 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.73263314 |
| 120 | MP0005365_abnormal_bile_salt | 0.71533133 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.71202635 |
| 122 | MP0005085_abnormal_gallbladder_physiolo | 0.70509273 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.70332862 |
| 124 | MP0010234_abnormal_vibrissa_follicle | 0.70165589 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.69953530 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.69273505 |
| 127 | MP0002971_abnormal_brown_adipose | 0.68879794 |
| 128 | MP0003453_abnormal_keratinocyte_physiol | 0.68838422 |
| 129 | MP0001324_abnormal_eye_pigmentation | 0.68389085 |
| 130 | MP0000858_altered_metastatic_potential | 0.68146795 |
| 131 | MP0009046_muscle_twitch | 0.66469128 |
| 132 | MP0003828_pulmonary_edema | 0.66275350 |
| 133 | MP0003252_abnormal_bile_duct | 0.65479681 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.64694565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.81639778 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.58518520 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.50596611 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.21810627 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.21444417 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.56083586 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.47456338 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.33061570 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.10264602 |
| 10 | Gingivitis (HP:0000230) | 3.93482611 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.91293379 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.91293379 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.91293379 |
| 14 | Axonal loss (HP:0003447) | 3.66806962 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.57879768 |
| 16 | Stomatitis (HP:0010280) | 3.49963638 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.46837852 |
| 18 | Glomerulonephritis (HP:0000099) | 3.43028091 |
| 19 | Joint hemorrhage (HP:0005261) | 3.41135970 |
| 20 | Recurrent skin infections (HP:0001581) | 3.36248937 |
| 21 | Loss of speech (HP:0002371) | 3.32022965 |
| 22 | Myocardial infarction (HP:0001658) | 3.30086100 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.27064632 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.27064632 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.27064632 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.15844749 |
| 27 | Prostate neoplasm (HP:0100787) | 3.13162675 |
| 28 | Mucopolysacchariduria (HP:0008155) | 3.12264948 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.12264948 |
| 30 | Cerebral aneurysm (HP:0004944) | 3.05539606 |
| 31 | Tetraparesis (HP:0002273) | 2.93704251 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.92616922 |
| 33 | Amyloidosis (HP:0011034) | 2.88492084 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85780967 |
| 35 | Obstructive lung disease (HP:0006536) | 2.85780967 |
| 36 | Orchitis (HP:0100796) | 2.82445792 |
| 37 | Thick nail (HP:0001805) | 2.79710578 |
| 38 | Nephritis (HP:0000123) | 2.78917068 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.66527863 |
| 40 | Optic neuritis (HP:0100653) | 2.66527863 |
| 41 | Nuclear cataract (HP:0100018) | 2.63847852 |
| 42 | Complement deficiency (HP:0004431) | 2.60891255 |
| 43 | Ocular albinism (HP:0001107) | 2.59795208 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.59653003 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59312602 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.58769669 |
| 47 | Pathologic fracture (HP:0002756) | 2.52652106 |
| 48 | Disinhibition (HP:0000734) | 2.50569594 |
| 49 | Gingival bleeding (HP:0000225) | 2.49221346 |
| 50 | Peripheral demyelination (HP:0011096) | 2.47783587 |
| 51 | J-shaped sella turcica (HP:0002680) | 2.46250548 |
| 52 | Prolonged partial thromboplastin time (HP:0003645) | 2.44066600 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.43324144 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.41817442 |
| 55 | Hyperacusis (HP:0010780) | 2.41244080 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.40120834 |
| 57 | * Bone pain (HP:0002653) | 2.40070419 |
| 58 | Cellulitis (HP:0100658) | 2.39268429 |
| 59 | Thoracic kyphosis (HP:0002942) | 2.37880620 |
| 60 | Myositis (HP:0100614) | 2.37818796 |
| 61 | Vasculitis (HP:0002633) | 2.36656520 |
| 62 | Cervical subluxation (HP:0003308) | 2.33956249 |
| 63 | Periodontitis (HP:0000704) | 2.33355367 |
| 64 | Broad face (HP:0000283) | 2.31251303 |
| 65 | Thin bony cortex (HP:0002753) | 2.30989700 |
| 66 | Abnormality of complement system (HP:0005339) | 2.29465737 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.28839707 |
| 68 | Purpura (HP:0000979) | 2.28420809 |
| 69 | Chronic otitis media (HP:0000389) | 2.27059295 |
| 70 | Abnormality of the thoracic spine (HP:0100711) | 2.26829707 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24702207 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24702207 |
| 73 | Upper limb amyotrophy (HP:0009129) | 2.17181492 |
| 74 | Distal upper limb amyotrophy (HP:0007149) | 2.17181492 |
| 75 | Urticaria (HP:0001025) | 2.15969990 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.15657008 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.13192707 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.13192707 |
| 79 | Prolonged neonatal jaundice (HP:0006579) | 2.12770719 |
| 80 | Frequent falls (HP:0002359) | 2.12223015 |
| 81 | Increased IgE level (HP:0003212) | 2.10456515 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.10029856 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.08081328 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 2.07164160 |
| 85 | Colitis (HP:0002583) | 2.07148394 |
| 86 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06475966 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.05446028 |
| 88 | Mitral stenosis (HP:0001718) | 2.05150442 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.03599280 |
| 90 | Progressive visual loss (HP:0000529) | 2.02879615 |
| 91 | Premature rupture of membranes (HP:0001788) | 2.02609909 |
| 92 | Peripheral hypomyelination (HP:0007182) | 1.99721844 |
| 93 | Upper motor neuron abnormality (HP:0002127) | 1.98714675 |
| 94 | Iris hypopigmentation (HP:0007730) | 1.98484428 |
| 95 | Polygenic inheritance (HP:0010982) | 1.95396456 |
| 96 | Joint stiffness (HP:0001387) | 1.95025898 |
| 97 | Apathy (HP:0000741) | 1.94993574 |
| 98 | Global brain atrophy (HP:0002283) | 1.94663735 |
| 99 | Xanthomatosis (HP:0000991) | 1.94623194 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 1.94552693 |
| 101 | Recurrent viral infections (HP:0004429) | 1.93736319 |
| 102 | Diminished motivation (HP:0000745) | 1.93406213 |
| 103 | Hematochezia (HP:0002573) | 1.93038876 |
| 104 | Increased connective tissue (HP:0009025) | 1.92732283 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 1.91916373 |
| 106 | Increased serum ferritin (HP:0003281) | 1.91714608 |
| 107 | Spontaneous hematomas (HP:0007420) | 1.91489562 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.88416204 |
| 109 | Hypercholesterolemia (HP:0003124) | 1.88191877 |
| 110 | Recurrent pneumonia (HP:0006532) | 1.88058107 |
| 111 | Submucous cleft hard palate (HP:0000176) | 1.86806832 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.86677637 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.86145740 |
| 114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86108380 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.85975760 |
| 116 | Increased CSF protein (HP:0002922) | 1.84932643 |
| 117 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84580544 |
| 118 | Deep venous thrombosis (HP:0002625) | 1.84025769 |
| 119 | Stridor (HP:0010307) | 1.83287399 |
| 120 | Aneurysm (HP:0002617) | 1.82820827 |
| 121 | Emphysema (HP:0002097) | 1.82185055 |
| 122 | Gastrointestinal inflammation (HP:0004386) | 1.79882544 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.78440519 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 1.78115302 |
| 125 | Spondylolisthesis (HP:0003302) | 1.77373061 |
| 126 | Polycythemia (HP:0001901) | 1.77186401 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77179994 |
| 128 | Retinal atrophy (HP:0001105) | 1.76528206 |
| 129 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.76232733 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.76077181 |
| 131 | Upper limb muscle weakness (HP:0003484) | 1.73526787 |
| 132 | Pustule (HP:0200039) | 1.72971019 |
| 133 | Abnormality of the periventricular white matter (HP:0002518) | 1.72616605 |
| 134 | Menorrhagia (HP:0000132) | 1.72191450 |
| 135 | Progressive neurologic deterioration (HP:0002344) | 1.72082652 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.71493905 |
| 137 | * Hypophosphatemia (HP:0002148) | 1.71187763 |
| 138 | Restrictive lung disease (HP:0002091) | 1.71165020 |
| 139 | Cerebral inclusion bodies (HP:0100314) | 1.70232189 |
| 140 | * Osteomyelitis (HP:0002754) | 1.69780256 |
| 141 | Esophageal varix (HP:0002040) | 1.69321113 |
| 142 | Vascular calcification (HP:0004934) | 1.69265937 |
| 143 | Ulnar bowing (HP:0003031) | 1.68847863 |
| 144 | Deformed sella turcica (HP:0002681) | 1.68805583 |
| 145 | Inflammation of the large intestine (HP:0002037) | 1.68582200 |
| 146 | Hypertriglyceridemia (HP:0002155) | 1.67882306 |
| 147 | Increased IgM level (HP:0003496) | 1.67411055 |
| 148 | Dementia (HP:0000726) | 1.65182236 |
| 149 | Malnutrition (HP:0004395) | 1.65121801 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.64594521 |
| 151 | Petechiae (HP:0000967) | 1.64021038 |
| 152 | Mitral regurgitation (HP:0001653) | 1.63881936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.86186706 |
| 2 | TRIB3 | 3.91615592 |
| 3 | RIPK4 | 3.63643760 |
| 4 | MAP3K14 | 3.26142861 |
| 5 | IRAK3 | 2.94405367 |
| 6 | ERN1 | 2.84053150 |
| 7 | TYK2 | 2.79635646 |
| 8 | TBK1 | 2.63094187 |
| 9 | IKBKE | 2.53609509 |
| 10 | MAP3K13 | 2.44933657 |
| 11 | IRAK4 | 2.37674877 |
| 12 | PBK | 2.29545202 |
| 13 | JAK1 | 2.22204952 |
| 14 | ICK | 2.18966052 |
| 15 | SMG1 | 2.16193954 |
| 16 | EPHB1 | 2.15374544 |
| 17 | KIT | 2.14791738 |
| 18 | MAP2K3 | 2.09072566 |
| 19 | TAOK3 | 2.02922214 |
| 20 | SIK2 | 1.97414750 |
| 21 | MAP3K11 | 1.81216285 |
| 22 | FGR | 1.76591383 |
| 23 | NME2 | 1.74766025 |
| 24 | FGFR4 | 1.74213427 |
| 25 | EEF2K | 1.69956697 |
| 26 | TGFBR2 | 1.66827037 |
| 27 | FES | 1.53676219 |
| 28 | CSK | 1.51429452 |
| 29 | TAOK2 | 1.50307364 |
| 30 | MAP3K3 | 1.48526761 |
| 31 | JAK3 | 1.46074693 |
| 32 | EPHA3 | 1.43809077 |
| 33 | CAMK1D | 1.43484198 |
| 34 | IKBKB | 1.39923817 |
| 35 | CAMK1G | 1.32205831 |
| 36 | MAP4K1 | 1.31207869 |
| 37 | MARK2 | 1.31131687 |
| 38 | RIPK1 | 1.30939195 |
| 39 | DAPK2 | 1.30182611 |
| 40 | HCK | 1.29973227 |
| 41 | INSRR | 1.26467578 |
| 42 | PKN2 | 1.23820122 |
| 43 | TTN | 1.22501080 |
| 44 | PRKD2 | 1.21862137 |
| 45 | PKN1 | 1.20710550 |
| 46 | TXK | 1.19926897 |
| 47 | IRAK1 | 1.19277394 |
| 48 | IRAK2 | 1.18578576 |
| 49 | PDGFRA | 1.17204565 |
| 50 | SIK1 | 1.16305843 |
| 51 | TAOK1 | 1.14105195 |
| 52 | RPS6KA2 | 1.09717291 |
| 53 | MST1R | 1.04892968 |
| 54 | GRK7 | 1.03067525 |
| 55 | BMX | 0.97798991 |
| 56 | JAK2 | 0.97570667 |
| 57 | PTK6 | 0.96427350 |
| 58 | TYRO3 | 0.96394086 |
| 59 | MAP3K6 | 0.94806806 |
| 60 | KSR2 | 0.93127149 |
| 61 | EIF2AK2 | 0.89541266 |
| 62 | RPS6KL1 | 0.88819109 |
| 63 | RPS6KC1 | 0.88819109 |
| 64 | CSF1R | 0.88612053 |
| 65 | GRK1 | 0.86517977 |
| 66 | SYK | 0.86204607 |
| 67 | TESK1 | 0.85876963 |
| 68 | TESK2 | 0.85873095 |
| 69 | LYN | 0.84486947 |
| 70 | PAK4 | 0.84290482 |
| 71 | MTOR | 0.83337406 |
| 72 | MAP3K10 | 0.83261988 |
| 73 | PRKD3 | 0.81468241 |
| 74 | CHUK | 0.80302821 |
| 75 | LCK | 0.79468142 |
| 76 | HIPK2 | 0.73623076 |
| 77 | BTK | 0.72733173 |
| 78 | SIK3 | 0.71691610 |
| 79 | DDR2 | 0.71579586 |
| 80 | CAMKK1 | 0.70275693 |
| 81 | FGFR3 | 0.69891436 |
| 82 | GRK6 | 0.68551320 |
| 83 | CLK1 | 0.68187711 |
| 84 | ARAF | 0.68109301 |
| 85 | RPS6KA6 | 0.67171557 |
| 86 | ABL2 | 0.65883550 |
| 87 | CASK | 0.65728345 |
| 88 | ERBB4 | 0.65634807 |
| 89 | MATK | 0.65240184 |
| 90 | FYN | 0.63586185 |
| 91 | ABL1 | 0.63280259 |
| 92 | MAPK7 | 0.61958635 |
| 93 | YES1 | 0.61614505 |
| 94 | MAP3K7 | 0.60938617 |
| 95 | MARK3 | 0.60723624 |
| 96 | PIK3CG | 0.59098945 |
| 97 | EGFR | 0.58202745 |
| 98 | PIM2 | 0.58001507 |
| 99 | PDPK1 | 0.56505234 |
| 100 | MAP2K6 | 0.54830532 |
| 101 | SGK1 | 0.54592599 |
| 102 | MAPK11 | 0.54409630 |
| 103 | RET | 0.54102934 |
| 104 | MOS | 0.53975477 |
| 105 | CDK6 | 0.50689332 |
| 106 | PDGFRB | 0.50486800 |
| 107 | LRRK2 | 0.49876598 |
| 108 | PRKCQ | 0.48550283 |
| 109 | PRKAA2 | 0.47971469 |
| 110 | EPHA2 | 0.47841902 |
| 111 | PRKCD | 0.47622108 |
| 112 | CDK4 | 0.46026414 |
| 113 | NTRK1 | 0.45767687 |
| 114 | ZAP70 | 0.45084205 |
| 115 | DYRK1B | 0.45075704 |
| 116 | PTK2 | 0.44869218 |
| 117 | MAP2K2 | 0.44544070 |
| 118 | MAP3K8 | 0.44511675 |
| 119 | PAK6 | 0.44038455 |
| 120 | TNK2 | 0.43919526 |
| 121 | PRPF4B | 0.42540632 |
| 122 | PDK1 | 0.42315933 |
| 123 | INSR | 0.40862365 |
| 124 | SRC | 0.38833567 |
| 125 | BMPR2 | 0.36815795 |
| 126 | PRKCE | 0.35943645 |
| 127 | DMPK | 0.35929675 |
| 128 | MAP3K1 | 0.35275953 |
| 129 | CDK12 | 0.34204845 |
| 130 | CDC42BPA | 0.33806175 |
| 131 | ADRBK2 | 0.32773973 |
| 132 | FER | 0.32546894 |
| 133 | MAPK12 | 0.32543228 |
| 134 | TRPM7 | 0.31981677 |
| 135 | NEK9 | 0.31568049 |
| 136 | PTK2B | 0.29579934 |
| 137 | PRKCH | 0.28849578 |
| 138 | WNK1 | 0.28573394 |
| 139 | PRKD1 | 0.27095135 |
| 140 | EPHB2 | 0.26081598 |
| 141 | DAPK3 | 0.25953348 |
| 142 | MAP3K5 | 0.25645422 |
| 143 | IGF1R | 0.24844334 |
| 144 | NUAK1 | 0.24213996 |
| 145 | SGK3 | 0.22840167 |
| 146 | ERBB2 | 0.22591144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.75839590 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.47052914 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.39679305 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38843817 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26982307 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12025978 |
| 7 | Malaria_Homo sapiens_hsa05144 | 1.94089716 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92815678 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91581639 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91531789 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.87950588 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82461496 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73204679 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.72100172 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.70267146 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70261395 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61042791 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56082086 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49790005 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47289047 |
| 21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.46978464 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46233747 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45081428 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.41214284 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37811814 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.33289242 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.32192572 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26028766 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23105047 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21536939 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19314564 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18904048 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18790930 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.18024295 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.16861436 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15812990 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13401557 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10872500 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.10179668 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08595596 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06734031 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06360021 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04170046 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02600000 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01921432 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.01036563 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.00094686 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99827011 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.99375408 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96446181 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.95499558 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94030010 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93585712 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92739596 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92235130 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.92124196 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91104119 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88156379 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87425943 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86737824 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83476919 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82215984 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81824934 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81538230 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.81107618 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79603269 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78214870 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78151897 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.78080629 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76649846 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75877731 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.75574525 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75523821 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74840175 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74760229 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72922986 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72408117 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71597830 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70645673 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70021759 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69519355 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.69380837 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68773723 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.67830173 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67733199 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.65443399 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64876154 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.63995183 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63682949 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63333487 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63169684 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62468353 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62382949 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62166146 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60653520 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60586614 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59248700 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58410473 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58288413 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57548506 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.56406345 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53087741 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52830756 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52138465 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51282460 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.50158239 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49251630 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49195669 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48248514 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47921662 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.46685053 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.46557386 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.46497520 |
| 114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46336849 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46246428 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.45835838 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44287755 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42191775 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41584991 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41431707 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41083909 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40913707 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40114337 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39335839 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37442958 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37212685 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36863720 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36584846 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35293311 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35237340 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35186803 |
| 132 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34067216 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33740068 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33336686 |
| 135 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32595808 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32580747 |
| 137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31666661 |

